The overlapping expression of the CDP/choline pathway genes and Mfsd2a in periportal hepatocytes predicts that they could synergize in periportal hepatocytes to maintain hepatic PC pools and protect the liver from NAFLD. Here, MFSD2A is linked to metabolic dysfunction-associated steatotic liver disease.